Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Odds-On-Favorite Ubl Confirmed As Next PhRMA CEO

This article was originally published in Scrip

Executive Summary

The Pharmaceutical Research and Manufacturers of America (PhRMA) late on Sept. 25 confirmed what had been widely speculated about in Washington and among industry insiders that AdvaMed CEO Stephen Ubl would be taking the reins as the next chief of the drug lobbying group.

Advertisement

Related Content

PhRMA Uses Allergan Stage In Campaign To Keep Focus On Industry's Reputation For Innovation
Advertisement
UsernamePublicRestriction

Register

SC029878

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel